ClinicalTrials.Veeva

Menu

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

G

Georg Dultz

Status

Active, not recruiting

Conditions

Esophageal Cancer
Head Neck Cancer
Gastrostomy

Treatments

Diagnostic Test: blue laser imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT04566367
JWGUHMED1-011

Details and patient eligibility

About

This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI is a new imaging technique that can easily be used within a standard gastroscopy.

Full description

Head-Neck cancers are a significant burden all around the world. Patients suffering from one tumor are at high risk for a second cancer or another precancerous lesion. Before or during cancer treatment a PEG is needed to maintain a sufficient calories intake. PEG is established by performing a standard gastroscopy.

This randomised study wants to compare the detection rates of standard white light endoscopy compared to the additional use of blue laser imaging for second cancers or precancerous lesions in participants presenting for PEG establishment.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All participants with the need of PEG due to head neck cancers or esophageal carcinoma

Exclusion criteria

  • Minors, pregnant women, contraindication for endoscopy, contraindications for establishment of a PEG

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

140 participants in 2 patient groups

Standard White Light Imaging
Active Comparator group
Description:
In this group the participants will be examined by white light endoscopy first and secondly with blue laser imaging technique during the same gastroscopy.
Treatment:
Diagnostic Test: blue laser imaging
Blue Light Imaging
Experimental group
Description:
In this group the participants will be examined by blue laser imaging technique first and secondly with standard white light during the same gastroscopy.
Treatment:
Diagnostic Test: blue laser imaging

Trial contacts and locations

1

Loading...

Central trial contact

Christiana Graf, MD; Mireen Friedrich-Rust, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems